QLT (QLTI) Announces Positive Data from QLT091001 LCA Treatment Phase 1b in Three Patients
Tweet Send to a Friend
QLT Inc. (Nasdaq: QLTI) today announced interim results from the first 3 subjects enrolled in a Phase 1b clinical proof-of-concept ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
